Plexiform Neurofibroma: Clinical Trials

4 trials for Plexiform Neurofibroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1

Follow Plexiform Neurofibroma: new trials by email Literature Review of Plexiform Neurofibroma trials Research Report on Plexiform Neurofibroma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours
Selumetinib - Neurofibromatosis Type 1, Plexiform Neurofibroma
Phase 1 / Phase 2CompletedGreat Ormond Street Hospital for Children NHS Foundation Trust142019-09-262024-04-04
Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas
Binimetinib - Neurofibromatosis Type 1, Plexiform Neurofibroma
Phase 2CompletedUniversity of Alabama at Birmingham452017-11-282025-05-02
Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas
RAD001: Everolimus - Neurofibromatosis Type 1, Plexiform Neurofibroma
Phase 2CompletedAssistance Publique - Hôpitaux de Paris302011-04-012014-11-14
Study of PEG-Intron for Plexiform Neurofibromas
PEG-Intron - Plexiform Neurofibroma
Phase 2CompletedUniversity of Pittsburgh862006-12-012017-11-06

Narrower conditions

Neurofibroma, Plexiform (4)  ·  Neurofibromatosis 1 (3)  ·  Neurofibromatoses (2)  ·  Neurofibroma (1)  ·  Optic Nerve Glioma (1)  ·  Peripheral Nervous System Neoplasms (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Nerve Sheath Neoplasms (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neuromuscular Diseases (4)  ·  Peripheral Nervous System Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Neoplastic Syndromes, Hereditary (3)  ·  Neurocutaneous Syndromes (3)  ·  Neurodegenerative Diseases (3)  ·  Neurofibroma (3)

Interventions

AZD 6244 (1)  ·  binimetinib (1)  ·  peginterferon alfa-2b (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  University of Alabama at Birmingham (1)  ·  University of Pittsburgh (1)

Countries

United States (2)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Bruce Korf, MD, PhD (1)  ·  Darren Hargrave, MB Bch (1)  ·  Jean Tersak, M.D. (1)  ·  Pierre Wolkenstein, MD, PhD (1)

Results publications

PMID 27510726, PMID 30339775